Inorganic Chemistry
Article
1
ΛM = 53.9 Ω−1 mol−1 cm2. H NMR (CD2Cl2, 25 °C) δ: 7.92−6.87
(m, 55 H, Ph), 3.58 (qnt, 6 H, CH2), 1.04 ppm (t, 9 H, CH3). 31P{1H}
NMR (CD2Cl2, −30 °C) δ: AB2 spin syst, δA 69.9, δB −6.7, JAB = 27.7
Anal. Calcd for C70H67BClN2O4OsP3 (1329.71) (11a). C, 63.23; H,
5.08; N, 2.11; Cl, 2.67. Found: C, 63.01; H, 5.17; N, 2.00; Cl, 2.54%.
1
ΛM = 53.4 Ω−1 mol−1 cm2. H NMR (CD2Cl2, 20 °C) δ: 7.73−6.87
Hz. IR (KBr): ν 2124 (m); νCO 1959 (s) cm−1.
N
(m, 55 H, Ph), 4.78 (t br, 1 H, NH), 4.46 (m br, 2 H, NH2), 3.27 ppm
(d, 9 H, CH3). 31P{1H} NMR (CD2Cl2, 25 °C) δ: AB2 spin syst, δA
73.35, δB −4.60, JAB = 26.7 Hz. IR (KBr): νNH 3379 (w), 3355 (m);
νCO 1964 (s) cm−1.
3
[OsCl(η1-15N3CH2C6H4-4-CH3)(CO)(PPh3)2{P(OEt)3}]BPh4 (5b1).
This complex was prepared exactly like the related unlabeled derivative
5b, using 4-CH3C6H4CH215N3 as a reagent. H NMR (CD2Cl2, 25
1
°C) δ: 7.69−6.77 (m, 54 H, Ph), 4.28 (s, 2 H, CH215N3), 3.55 (qnt, 6
H, CH2 phos), 2.37 (s, 3 H, CH3 p-tolyl), 1.05 ppm (t, 9 H, CH3
phos). 31P{1H} NMR (CD2Cl2, −30 °C) δ: AB2X spin syst (X = 15N),
δA 65.15, δB −5.09, JAB = 27.2, JAX = 55.7, JBX = 27.7 Hz. 15N NMR
(CD2Cl2, −30 °C) δ: −69.6 (s, 15N), −368.4 ppm (m, 15N). IR (KBr):
Anal. Calcd for C73H73BClN2O4OsP3 (1371.79) (11b). C, 63.92; H,
5.36; N, 2.04; Cl, 2.58. Found: C, 63.72; H, 5.25; N, 2.13; Cl, 2.50%.
1
ΛM = 52.5 Ω−1 mol−1 cm2. H NMR (CD2Cl2, 20 °C) δ: 7.75−6.87
(m, 55 H, Ph), 4.83 (t br, 1 H, NH), 4.31 (m br, 2 H, NH2), 3.61 (qnt,
6 H, CH2), 1.14 ppm (t, 9 H, CH3). 31P{1H} NMR (CD2Cl2, 25 °C)
δ: AB2 spin syst, δA 78.9, δB 5.0, JAB = 26.7 Hz. IR (KBr): νNH 3249
(w), 3318 (m); νCO 1956 (s) cm−1.
2118 (m); νCO 1953 (s) cm−1.
15N3
ν
[OsCl{η1-NHC(H)C6H4-4-CH3}(CO)(PPh3)2{P(OEt)3}]BPh4
[OsCl(C6H5NNH)(CO)(PPh3)2L]BPh4 (12) [L = P(OMe)3 (a),
P(OEt)3 (b)]. Method A: A solid sample of the appropriate
phenylhydrazine complex [OsCl(C6H5NHNH2)(CO)(PPh3)2L]BPh4
(11) (0.1 mmol) was placed in a 25-mL three-necked round-bottomed
flask fitted with a solid-addition side arm containing a slight excess of
Pb(OAc)4 (0.11 mmol, 49 mg). Dichloromethane (8 mL) was added,
the solution cooled to −30 °C and Pb(OAc)4 portionwise was added
over 20−30 min to the cold stirring solution. The solution was
brought to 0 °C, stirred for 5 min, and then the solvent was removed
at 0 °C under reduced pressure. The oil obtained was triturated with
ethanol (2 mL) containing NaBPh4 (0.1 mmol, 34 mg), and the
resulting solution was stirred at 0 °C until a pale-yellow solid separated
out, which was filtered and crystallized from CH2Cl2 and ethanol; yield
≥ 55%.
(8b). A solution of the complex [OsCl(η1-N3CH2C6H4-4-CH3)(CO)-
(PPh3)2{P(OEt)3}]BPh4 (5b) (100 mg, 0.07 mmol) in CH2Cl2 (5
mL) and EtOH (7 mL) was stirred at room temperature in the
daylight for 10 h. The solvent was then removed under reduced
pressure to give an oil, which was treated with ethanol (2 mL)
containing NaBPh4 (0.1 mmol, 34 mg). A white solid slowly separated
out, which was filtered and crystallized from dichloromethane and
ethanol; yield ≥ 60%. Anal. calcd for C75H74BClNO4OsP3 (1382.81):
C, 65.14; H, 5.39; N, 1.01; Cl, 2.56. Found: C, 64.98; H, 5.51; Cl,
2.42%. ΛM = 53.0 Ω−1 mol−1 cm2. H NMR (CD2Cl2, 25 °C) δ: 8.29
1
(d br, 1 H, NH, JHH = 22.0), 7.75 (d, 1 H, NCH, JHH = 22.0 Hz),
7.91−6.87 (m, 54 H, Ph), 3.55 (qnt, 6 H, CH2 phos), 2.39 (s, 3 H,
CH3 p-tolyl), 0.99 ppm (t, 9 H, CH3 phos). 31P{1H} NMR (CD2Cl2,
25 °C) δ: AB2 spin syst, δA 70.0, δB −6.5, JAB = 23.0 Hz. IR (KBr): νNH
3289 (m); νCO 1952 (s) cm−1.
Anal. Calcd for C70H65BClN2O4OsP3 (1327.69) (12a). C, 63.32; H,
4.93; N, 2.11; Cl, 2.67. Found: C, 63.11; H, 5.02; N, 2.17; Cl, 2.55%.
[OsCl(RNHNH2)(CO)(PPh3)2L]BPh4 (9−11) [R = H (9), CH3 (10),
C6H5 (11); L = P(OMe)3 (a), P(OEt)3 (b)]. Triflic acid (0.11 mmol, 9.7
μL) was added to a solution of the appropriate complex OsHCl-
(CO)(PPh3)2L (2) (0.1 mmol) in 5 mL of CH2Cl2 cooled to −196
°C. The reaction mixture was brought to room temperature, stirred for
1 h, and then cooled again to −196 °C. An excess of the appropriate
hydrazine (0.22 mmol) was added to the resulting solution, which was
brought to room temperature and stirred for 3 h. The solvent was
removed under reduced pressure to give an oil, which was treated with
ethanol (2 mL) containing an excess of NaBPh4 (0.2 mmol, 68 mg). A
white solid slowly separated out, which was filtered and crystallized
from dichloromethane and ethanol; yield ≥ 75%.
Λ
M = 51.1 Ω−1 mol−1 cm2. 1H NMR (CD2Cl2, 20 °C) δ: 12.46 (d br, 1
H, NH, JPH = 12.0 Hz), 7.94−6.66 (m, 55 H, Ph), 3.25 ppm (d, 9 H,
CH3). 31P{1H} NMR (CD2Cl2, 25 °C) δ: AB2 spin syst, δA 80.56, δB
−7.40, JAB = 27.9 Hz. IR (KBr): νCO 1982 (s) cm−1.
Anal. Calcd for C73H71BClN2O4OsP3 (1369.77) (12b). C, 64.01; H,
5.22; N, 2.05; Cl, 2.59. Found: C, 63.83; H, 5.38; N, 2.17; Cl, 2.45%.
Λ
M = 52.7 Ω−1 mol−1 cm2. 1H NMR (CD2Cl2, 20 °C) δ: 12.34 (d br, 1
H, NH, JPH = 12.7 Hz), 7.92−6.65 (m, 55 H, Ph), 3.50 (qnt, 6 H,
CH2), 1.04 ppm (t, 9 H, CH3). 31P{1H} NMR (CD2Cl2, 25 °C) δ: AB2
spin syst, δA 77.1, δB −7.9, JAB = 27.3 Hz. IR (KBr): νCO 1974 (s)
cm−1.
[OsCl(ArNNH)(CO)(PPh3)2L]BPh4 (12, 13) [Ar = C6H5 (12), 4-
CH3C6H4 (13); L = P(OMe)3 (a), P(OEt)3 (b)]. Method B: in a 25-mL
three-necked round-bottomed flask were placed solid samples of the
appropriate carbonyl complex OsHCl(CO)(PPh3)2L (2) (0.1 mmol),
an excess of the appropriate aryldiazonium cation [ArN2]BF4 (0.25
mmol), and 10 mL of CH2Cl2. The reaction mixture was stirred at
room temperature for 4 h, and then, the solvent was removed under
reduced pressure. The oil obtained was treated with ethanol (2 mL)
containing an excess of NaBPh4 (0.2 mmol, 68 mg). The resulting
solution was stirred until a pale-yellow solid separated out, which was
filtered and crystallized from CH2Cl2 and EtOH; yield ≥ 80.
Anal. Calcd for C71H67BClN2O4OsP3 (1341.72) (13a). C, 63.56; H,
5.03; N, 2.09; Cl, 2.64. Found: C, 63.34; H, 4.92; Cl, 2.75; N, 1.98%.
Anal. Calcd for C64H63BClN2O4OsP3 (1253.61) (9a). C, 61.32; H,
5.07; N, 2.23; Cl, 2.83. Found: C, 61.07; H, 5.20; N, 2.11; Cl, 2.96%.
1
ΛM = 54.6 Ω−1 mol−1 cm2. H NMR (CD2Cl2, 20 °C) δ: 7.96−6.80
(m, 50 H, Ph), 4.00 (br, 2 H, NH2), 3.18 (d, 9 H, CH3), 2.68 ppm (m
br, 2 H, NH2). 31P{1H} NMR (CD2Cl2, 25 °C) δ: AB2 spin syst, δA
76.9, δB −5.02, JAB = 26.7 Hz. IR (KBr): νNH 3367, 3278, 3216 (w);
νCO 1963 (s) cm−1.
Anal. Calcd for C67H69BClN2O4OsP3 (1295.69) (9b). C, 62.11; H,
5.37; N, 2.16; Cl, 2.74. Found: C, 62.29; H, 5.24; N, 2.24; Cl, 2.52%.
1
ΛM = 53.6 Ω−1 mol−1 cm2. H NMR (CD2Cl2, 20 °C) δ: 7.90−6.86
(m, 50 H, Ph), 3.55 (m, 6 H, CH2), 3.13, 2.70 (m br, 4 H, NH2), 1.00
ppm (t, 9 H, CH3). 31P{1H} NMR (CD2Cl2, 25 °C) δ: AB2 spin syst,
δA 68.2, δB 7.83, JAB = 22.0 Hz. IR (KBr): νNH 3339 (w), 3272 (m),
3253 (w); νCO 1967 (s) cm−1.
Λ
M = 54.4 Ω−1 mol−1 cm2. 1H NMR (CD2Cl2, 20 °C) δ: 12.22 (d br, 1
H, NH), 7.92−6.59 (m, 54 H, Ph), 3.25 (d, 9 H, CH3 phos), 2.39 ppm
(s, 3 H, CH3 p-tolyl). 31P{1H} NMR (CD2Cl2, 25 °C) δ: AB2 spin syst,
δA 80.9, δB −7.25, JAB = 27.0 Hz. IR (KBr): νCO 1970 (s) cm−1.
Anal. Calcd for C74H73BClN2O4OsP3 (1383.80) (13b). C, 64.23; H,
5.32; N, 2.02; Cl, 2.56. Found: C, 64.01; H, 5.43; N, 2.12; Cl, 2.43%.
Anal. Calcd for C65H65BClN2O4OsP3 (1267.64) (10a). C, 61.59; H,
5.17; N, 2.21; Cl, 2.80. Found: C, 61.36; H, 5.04; N, 2.30; Cl, 2.68%.
1
ΛM = 51.4 Ω−1 mol−1 cm2. H NMR (CD2Cl2, 20 °C) δ: 7.79−6.88
(m, 50 H, Ph), 3.87 (m br, 2 H, NH2), 3.14 (d, 9 H, CH3 phos), 2.71
(m, 1 H, NH), 1.50 ppm (d, 3 H, NCH3). 31P{1H} NMR (CD2Cl2, 25
°C) δ: AB2 spin syst, δA 77.2, δB −4.39, JAB = 26.7 Hz. IR (KBr): νNH
3310 (w), 3254 (m), 3183 (w); νCO 1964 (s) cm−1.
Λ
M = 53.6 Ω−1 mol−1 cm2. 1H NMR (CD2Cl2, 20 °C) δ: 12.11 (d br, 1
H, NH, JPH = 8.0 Hz), 7.80−6.57 (m, 54 H, Ph), 3.50 (m, 6 H, CH2),
2.39 (s, 3 H, CH3 p-tolyl), 1.04 ppm (d, 9 H, CH3 phos). 31P{1H}
NMR (CD2Cl2, 25 °C) δ: AB2 spin syst, δA 77.41, δB −7.78, JAB = 26.7
Hz. IR (KBr): νCO 1969 (s) cm−1.
Anal. Calcd for C68H71BClN2O4OsP3 (1309.72) (10b). C, 62.36; H,
5.46; N, 2.14; Cl, 2.71. Found: C, 62.13; H, 5.34; N, 2.06; Cl, 2.82%.
1
ΛM = 55.7 Ω−1 mol−1 cm2. H NMR (CD2Cl2, 20 °C) δ: 7.81−6.84
15
[OsCl(CO)(C6H5N NH)(PPh3)2{P(OEt)3}]BPh4 (12b1). This
(m, 50 H, Ph), 3.74 (br, 2 H, NH2), 3.38 (qnt, 6 H, CH2), 2.75 (m, 1
H, NH), 1.52 (d, 3 H, NCH3), 0.97 ppm (t, 9 H, CH3 phos). 31P{1H}
NMR (CD2Cl2, 25 °C) δ: AB2 spin syst, δA 73.8, δB −4.83, JAB = 26.7
Hz. IR (KBr): νNH 3310 (w), 3258 (m), 3183 (w); νCO 1962 (s) cm−1.
complex was prepared exactly like the related unlabeled derivative
15
−
1
12b (method B), using [C6H5N N]+BF4 as a reagent. H NMR
1
15
1
N
31P
(CD2Cl2, 20 °C) δ: 12.34 (dd, 1 H, NH, J H = 65.11, J H = 12.7
Hz), 7.91−6.65 (m, 55 H, Ph), 3.50 (qnt, 6 H, CH2), 1.04 ppm (t, 9
C
dx.doi.org/10.1021/ic302483e | Inorg. Chem. XXXX, XXX, XXX−XXX